We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WRB icon
1701
W.R. Berkley
WRB
$26.4B
$34K ﹤0.01%
1,721
-11,668
-87% -$210K
HT
1702
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$34K ﹤0.01%
+1,607
New +$31.3K
GTS
1703
DELISTED
Triple-S Management Corporation
GTS
$34K ﹤0.01%
1,709
+1,499
+714% +$31.2K
ADXS
1704
DELISTED
Advaxis Inc
ADXS
$34K ﹤0.01%
+315
New +$42.5K
WGL
1705
DELISTED
Wgl Holdings
WGL
$34K ﹤0.01%
448
-517
-54% -$34.8K
APOL
1706
DELISTED
Apollo Education Group Inc Class A
APOL
$34K ﹤0.01%
3,390
+3,185
+1,554% +$29.1K
AXDX
1707
DELISTED
Accelerate Diagnostics
AXDX
$33K ﹤0.01%
+158
New +$37.5K
CBOE icon
1708
Cboe Global Markets
CBOE
$30.2B
$33K ﹤0.01%
447
-2,411
-84% -$166K
CIM
1709
Chimera Investment
CIM
$1.01B
$33K ﹤0.01%
650
-4,095
-86% -$201K
CRD.A icon
1710
Crawford & Co Class A
CRD.A
$632M
$33K ﹤0.01%
3,550
+3,058
+622% +$29.3K
CRL icon
1711
Charles River Laboratories
CRL
$12.7B
$33K ﹤0.01%
431
-1,741
-80% -$132K
CYH icon
1712
Community Health Systems
CYH
$417M
$33K ﹤0.01%
5,845
-12,543
-68% -$87.1K
HRTG icon
1713
Heritage Insurance Holdings
HRTG
$1.03B
$33K ﹤0.01%
+2,092
New +$29.1K
IOVA icon
1714
Iovance Biotherapeutics
IOVA
$2.77B
$33K ﹤0.01%
+4,721
New +$32.5K
ITUB icon
1715
Itaú Unibanco
ITUB
$89.2B
$33K ﹤0.01%
6,665
-102,037
-94% -$523K
NPO icon
1716
Enpro
NPO
$7.12B
$33K ﹤0.01%
490
+190
+63% +$11.4K
RARE icon
1717
Ultragenyx Pharmaceutical
RARE
$2.56B
$33K ﹤0.01%
465
+300
+182% +$21.3K
RBA icon
1718
RB Global
RBA
$17.5B
$33K ﹤0.01%
975
-2,483
-72% -$90.2K
TEF
1719
DELISTED
Telefonica
TEF
$33K ﹤0.01%
4,495
+2,950
+191% +$21.6K
XEL icon
1720
Xcel Energy
XEL
$48.2B
$33K ﹤0.01%
828
-7,947
-91% -$318K
HZN
1721
DELISTED
Horizon Global Corporation
HZN
$33K ﹤0.01%
+1,378
New +$31K
BT
1722
DELISTED
BT Group plc (ADR)
BT
$33K ﹤0.01%
+1,433
New +$33.1K
PETX
1723
DELISTED
Aratana Therapeutics, Inc.
PETX
$33K ﹤0.01%
+4,598
New +$37.2K
SIGM
1724
DELISTED
Sigma Designs Inc
SIGM
$33K ﹤0.01%
5,499
+5,399
+5,399% +$38.8K
UN
1725
DELISTED
Unilever NV New York Registry Shares
UN
$33K ﹤0.01%
804
-997
-55% -$41.3K
67 68
69
70 71

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.